Abstract: An example liquid mirror includes a first ionic liquid and a second ionic liquid. The first and second ionic liquids are immiscible with each other. The liquid mirror also includes a plurality of reflective particles configured to self-assemble at an interface between the first and second ionic liquids.

Abstract: Antibodies that bind ICOS (Inducible T cell Co-Stimulator). Therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells, to stimulate the immune system of patients, including use in treating cancers. Methods of producing anti-ICOS antibodies, including species cross-reactive antibodies, using transgenic knock-out mice.

Abstract: An anode for an electrochemical cell comprises a lithium metal or lithium metal alloy, and a polymer coating deposited on the lithium metal or lithium metal alloy. The polymer coating is doped with lithium ions and comprises a polyisocyanurate material. The polyisocyanurate material contains ether- and/or silicone-containing further groups. The ether-containing group is a polyether, and/or wherein the silicone-containing group is a siloxane group.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: A method for removing liquid from a slurry includes: (i) feeding the slurry into the inlet of a press; (ii) removing liquid from the slurry as the slurry advances through a deliquifying section of the press, thereby producing a pressate stream; (iii) forming a plug of material as the slurry is advanced through a plug formation section of the press; (iv) advancing the plug of material to a discharge section of the press; and (v) removing additional liquid from the plug of material by operating the press so that the pressure in the discharge section of the press is greater than the pressure of the pressate stream by at least 2 psi. The present invention also relates to a method for controlling discharge consistency from a press, without provision of discharge restrictors, by varying the pressure differential between a discharge section of the press and a pressate stream.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: Discharging pretreated biomass from a pretreatment reactor and mixing the discharged pretreated biomass with a cooling liquid in a vessel provides a cooled slurry having a consistency that is less than about 12 wt %. Since the consistency is relatively low, the cooled slurry may be pumped to a higher elevation using standard pumping equipment. At the higher elevation, the cooled slurry may be separated into a first stream comprising a liquid component of the slurry and a second other stream comprising a solid component of the slurry (e.g., having a consistency between about 15 wt % and 40 about wt %). The solid component may be fed to an inlet of a hydrolysis reactor, while the liquid component may be fed to a cooling system that provides a cooled stream. The cooled stream may then be cycled back to the vessel.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: A method for removing liquid from a slurry includes: (i) feeding the slurry into the inlet of a press; (ii) removing liquid from the slurry as the slurry advances through a deliquifying section of the press, thereby producing a pressate stream; (iii) forming a plug of material as the slurry is advanced through a plug formation section of the press; (iv) advancing the plug of material to a discharge section of the press; and (v) removing additional liquid from the plug of material by operating the press so that the pressure in the discharge section of the press is greater than the pressure of the pressate stream by at least 2 psi. The present invention also relates to a method for controlling discharge consistency from a press, without provision of discharge restrictors, by varying the pressure differential between a discharge section of the press and a pressate stream.

Abstract: The method includes the following steps: (i) feeding a slurry into the inlet of a press; (ii) removing liquid from the slurry as the slurry advances through a deliquefying section of the press, thereby producing a pressate stream; (iii) forming a plug of material as the slurry is advanced through a plug formation section of the press; (iv) advancing the plug of material to a discharge section of the press; and (v) removing additional liquid from the plug of material by operating the press so that the pressure in the discharge section of the press is greater than the pressure of the pressate stream by at least 2 psi. There is also described a method for controlling discharge consistency from a press, without provision of discharge restrictors, by varying a pressure differential between a discharge section of the press and a pressate stream.

Abstract: An expansion bridge chip for a modular chip system includes at least one upstream interface for communicating with an application processor module, a plurality of downstream interfaces for communicating with peripheral modules, and an upstream address decoder on each interface for directing data on the upstream interface to a downstream interface. In such an expansion bridge chip, each upstream interface may have a first bandwidth, each downstream interface may have a respective bandwidth, and the expansion bridge chip may be balanced, such that a sum of all respective bandwidths of the plurality of downstream interfaces is equal to the first bandwidth. Alternatively, each upstream interface may have a first bandwidth, each of the downstream interfaces may have a respective bandwidth, and the expansion bridge chip is unbalanced, such that a sum of all respective bandwidths of the plurality of downstream interfaces exceeds the first bandwidth, and interfaces contend for bandwidth.

Abstract: According to the present disclosure, there is an electrode for a lithium sulphur cell. The electrode comprises a matrix deposited on a current collector, wherein the matrix comprises an electrically conductive material, an electroactive sulphur material and a binder comprising a polymer that is crosslinked to form a crosslinked polymer network.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: The present invention relates to an anode for an electrochemical cell, said anode comprising a lithium metal or lithium metal alloy, and a polymer coating deposited on the lithium metal or lithium metal alloy, wherein the polymer coating is doped with lithium ions and comprises a polyisocyanurate material.

Abstract: The present invention is an inflatable balloon which is enclosed by an expandable cover which becomes increasingly porous/permeable during expansion. The balloon is coated or enclosed with a matrix which contains a pharmaceutically active agent. During expansion of the balloon, the pharmaceutically active agent is released or extruded through the expandable cover into a body cavity such as an artery or vein. The present invention also provides for a method of treating a disease or condition by delivering the inflatable balloon to a particular body cavity.

Abstract: Discharging pretreated biomass from a pretreatment reactor and mixing the discharged pretreated biomass with a cooling liquid in a vessel provides a cooled slurry having a consistency that is less than about 12 wt %. Since the consistency is relatively low, the cooled slurry may be pumped to a higher elevation using standard pumping equipment. At the higher elevation, the cooled slurry may be separated into a first stream comprising a liquid component of the slurry and a second other stream comprising a solid component of the slurry (e.g., having a consistency between about 15 wt % and 40 about wt %). The solid component may be fed to an inlet of a hydrolysis reactor, while the liquid component may be fed to a cooling system that provides a cooled stream. The cooled stream may then be cycled back to the vessel.

Abstract: The method includes the following steps: (i) feeding a slurry into the inlet of a press; (ii) removing liquid from the slurry as the slurry advances through a deliquefying section of the press, thereby producing a pressate stream; (iii) forming a plug of material as the slurry is advanced through a plug formation section of the press; (iv) advancing the plug of material to a discharge section of the press; and (v) removing additional liquid from the plug of material by operating the press so that the pressure in the discharge section of the press is greater than the pressure of the pressate stream by at least 2 psi. There is also described a method for controlling discharge consistency from a press, without provision of discharge restrictors, by varying a pressure differential between a discharge section of the press and a pressate stream.